|
REV1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.30229160788531E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.813600E-01 |
| Stage1-vs-Stage3 |
6.639600E-02 |
| Stage1-vs-Stage4 |
8.499600E-03 |
| Stage2-vs-Stage3 |
4.525200E-01 |
| Stage2-vs-Stage4 |
1.431630E-01 |
| Stage3-vs-Stage4 |
4.334800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.9494999947689E-08 |
| Normal-vs-Asian |
2.42029729591309E-11 |
| Caucasian-vs-AfricanAmerican |
3.507800E-01 |
| Caucasian-vs-Asian |
9.658200E-02 |
| AfricanAmerican-vs-Asian |
7.785200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.096400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.7372000000202E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.106000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.510200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.170400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.809840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.581400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.780200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.402570E-04 |
| Classical-VS-Follicular |
9.893000E-01 |
| Classical-VS-Other |
9.798600E-01 |
| Classical-VS-Normal |
1.65867319878998E-12 |
| Tall-VS-Follicular |
2.380100E-03 |
| Tall-VS-Other |
6.900400E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
9.876800E-01 |
| Follicular-VS-Normal |
1.7643664307343E-12 |
| Other-VS-Normal |
5.590500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.20934381900406E-14 |
| N0-vs-N1 |
6.597400E-01 |
|
|
